Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Feedback
    • Reprint Information
    • Subscriptions
  • ASN Kidney News
  • Other
    • ASN Publications
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Feedback
    • Reprint Information
    • Subscriptions
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum
Original ArticleMaintenance Dialysis
You have accessRestricted Access

Apixaban versus Warfarin for Treatment of Venous Thromboembolism in Patients Receiving Long-Term Dialysis

James B. Wetmore, Charles A. Herzog, Heng Yan, Jorge L. Reyes, Eric D. Weinhandl and Nicholas S. Roetker
CJASN May 2022, 17 (5) 693-702; DOI: https://doi.org/10.2215/CJN.14021021
James B. Wetmore
1Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, Minnesota
2Division of Nephrology, Hennepin Healthcare and Department of Medicine, University of Minnesota, Minneapolis, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James B. Wetmore
Charles A. Herzog
1Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, Minnesota
3Division of Cardiology, Hennepin Healthcare, and Department of Medicine, University of Minnesota, Minneapolis, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heng Yan
1Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Heng Yan
Jorge L. Reyes
4Division of Cardiology, University of Minnesota, Minneapolis, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric D. Weinhandl
1Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, Minnesota
5Department of Pharmaceutical Care and Health Systems, University of Minnesota, Minneapolis, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eric D. Weinhandl
Nicholas S. Roetker
1Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicholas S. Roetker
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Article Information

vol. 17 no. 5 693-702
DOI 
https://doi.org/10.2215/CJN.14021021
PubMed 
35470214

Published By 
American Society of Nephrology
Print ISSN 
1555-9041
Online ISSN 
1555-905X
History 
  • Received October 23, 2021
  • Accepted March 4, 2022
  • Published online May 6, 2022.

Article Versions

  • Earlier version (April 25, 2022 - 11:23).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2022 by the American Society of Nephrology

Author Information

  1. James B. Wetmore1,2,
  2. Charles A. Herzog1,3,
  3. Heng Yan1,
  4. Jorge L. Reyes4,
  5. Eric D. Weinhandl1,5,
  6. Nicholas S. Roetker1
  1. 1Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, Minnesota
  2. 2Division of Nephrology, Hennepin Healthcare and Department of Medicine, University of Minnesota, Minneapolis, Minnesota
  3. 3Division of Cardiology, Hennepin Healthcare, and Department of Medicine, University of Minnesota, Minneapolis, Minnesota
  4. 4Division of Cardiology, University of Minnesota, Minneapolis, Minnesota
  5. 5Department of Pharmaceutical Care and Health Systems, University of Minnesota, Minneapolis, Minnesota
  1. Correspondence:
    Dr. James B. Wetmore, Chronic Disease Research Group, Hennepin Healthcare Research Institute, 701 Park Avenue, Suite S4.100, Minneapolis, MN 55415. Email: james.wetmore{at}hcmed.org

Statistics from Altmetric.com

Article usage

Article usage: April 2022 to April 2022

AbstractFullPdf
Apr 20221411279140
PreviousNext
Back to top

In this issue

Clinical Journal of the American Society of Nephrology: 17 (5)
Clinical Journal of the American Society of Nephrology
Vol. 17, Issue 5
May 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in CJASN.
Enter multiple addresses on separate lines or separate them with commas.
Apixaban versus Warfarin for Treatment of Venous Thromboembolism in Patients Receiving Long-Term Dialysis
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Apixaban versus Warfarin for Treatment of Venous Thromboembolism in Patients Receiving Long-Term Dialysis
James B. Wetmore, Charles A. Herzog, Heng Yan, Jorge L. Reyes, Eric D. Weinhandl, Nicholas S. Roetker
CJASN May 2022, 17 (5) 693-702; DOI: 10.2215/CJN.14021021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Apixaban versus Warfarin for Treatment of Venous Thromboembolism in Patients Receiving Long-Term Dialysis
James B. Wetmore, Charles A. Herzog, Heng Yan, Jorge L. Reyes, Eric D. Weinhandl, Nicholas S. Roetker
CJASN May 2022, 17 (5) 693-702; DOI: 10.2215/CJN.14021021
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosures
    • Funding
    • Acknowledgments
    • Authors Contributions
    • Data Sharing Statement
    • Supplemental Material
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

Original Article

  • Evaluation of Conflicts of Interest among Participants of the Japanese Nephrology Clinical Practice Guideline
  • Fracture Risk of Sodium-Glucose Cotransporter-2 Inhibitors in Chronic Kidney Disease
  • Diagnostic Performance of Fractional Excretion of Sodium for the Differential Diagnosis of Acute Kidney Injury
Show more Original Article

Maintenance Dialysis

  • Medicare Bundled Payment Policy on Anemia Care, Major Adverse Cardiovascular Events, and Mortality among Adults Undergoing Hemodialysis
  • Association of Serum Phosphate with Efficacy of Statin Therapy in Hemodialysis Patients
Show more Maintenance Dialysis

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Related Articles

  • Treatment Options for Venous Thromboembolism in Patients Receiving Dialysis
  • PubMed
  • Google Scholar

Keywords

  • apixaban
  • direct oral anticoagulants
  • warfarin
  • deep vein thrombosis
  • ESKD
  • end stage kidney disease
  • dialysis

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe to ASN Journals

© 2022 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire